<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines carry a translocated c-myc gene and, in 60-80% of cases, exhibit mutations in the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the potential role of the p53 gene in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> tumorigenicity using an in vitro assay that measures p53-dependent cell cycle arrest in the G1 phase of the cell cycle and an in vivo athymic murine model that detects differences in the tumorigenicity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>A highly significant inverse correlation was found between the ability of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells to arrest in G1 after irradiation and their tumorigenicity in athymic mice, consistent with the notion that loss of p53 function is associated with increased tumorigenicity </plain></SENT>
<SENT sid="3" pm="."><plain>Inactivation of <z:mp ids='MP_0002169'>wild-type</z:mp> (wt) p53 function by expression of the <z:e sem="disease" ids="C0850011,C0850009" disease_type="Disease or Syndrome" abbrv="">human papillomavirus</z:e> E6 protein in the AG876V <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell line, which carries both wt and mutant p53 proteins, rendered the cell line significantly more tumorigenic in athymic mice </plain></SENT>
<SENT sid="4" pm="."><plain>Transfection of the wt p53 gene into the p53 mutant and highly tumorigenic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-41 cell line caused it to acquire wt p53 function and rendered it less tumorigenic in mice </plain></SENT>
<SENT sid="5" pm="."><plain>In addition to confirming a role for the loss of p53 function in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, the data demonstrate that wt p53 protein can reduce <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> tumorigenicity in vivo </plain></SENT>
</text></document>